These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 35180141)
41. Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer. Gong X; Zhang H J Clin Lab Anal; 2020 Jul; 34(7):e23268. PubMed ID: 32118318 [TBL] [Abstract][Full Text] [Related]
42. Clinical utility of serum tumor markers in the diagnosis of malignant intestinal occlusion. A prospective observational study. Marrelli D; Caruso S; Neri A; Pedrazzani C; Capuano L; Mazzei MA; Roviello F Int J Biol Markers; 2011; 26(1):58-64. PubMed ID: 21279957 [TBL] [Abstract][Full Text] [Related]
43. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients? Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907 [TBL] [Abstract][Full Text] [Related]
44. Diagnostic and economic value of carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 72-4 in gastrointestinal cancers. Liu HN; Yao C; Wang XF; Zhang NP; Chen YJ; Pan D; Zhao GP; Shen XZ; Wu H; Liu TT World J Gastroenterol; 2023 Jan; 29(4):706-730. PubMed ID: 36742169 [TBL] [Abstract][Full Text] [Related]
45. Evaluating the significance of expression of CEA mRNA and levels of CEA and its related proteins in colorectal cancer patients. Wang W; Li Y; Zhang X; Jing J; Zhao X; Wang Y; Han C J Surg Oncol; 2014 Apr; 109(5):440-4. PubMed ID: 24783267 [TBL] [Abstract][Full Text] [Related]
46. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022 [TBL] [Abstract][Full Text] [Related]
47. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy. Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876 [TBL] [Abstract][Full Text] [Related]
48. Serum CEA and CA19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia. Zhai H; Huang J; Yang C; Fu Y; Yang B Clin Lab; 2018 Mar; 64(3):351-356. PubMed ID: 29739122 [TBL] [Abstract][Full Text] [Related]
49. Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals. Thorsen SB; Lundberg M; Villablanca A; Christensen SL; Belling KC; Nielsen BS; Knowles M; Gee N; Nielsen HJ; Brünner N; Christensen IJ; Fredriksson S; Stenvang J; Assarsson E J Transl Med; 2013 Oct; 11():253. PubMed ID: 24107468 [TBL] [Abstract][Full Text] [Related]
50. Circulating sialyl Lewis(x), sialyl Lewis(a), and sialyl Tn antigens in colorectal cancer patients: multivariate analysis of predictive factors for serum antigen levels. Nakagoe T; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Kurosaki N; Yasutake T; Ayabe H J Gastroenterol; 2001 Mar; 36(3):166-72. PubMed ID: 11291879 [TBL] [Abstract][Full Text] [Related]
51. Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer. Hermunen K; Soveri LM; Boisen MK; Mustonen HK; Dehlendorff C; Haglund CH; Johansen JS; Osterlund P Acta Oncol; 2020 Dec; 59(12):1416-1423. PubMed ID: 32790589 [TBL] [Abstract][Full Text] [Related]
52. [Predictive value of preoperative detection of CEA and CA199 for prognosis in patients with stage II-III colorectal cancer]. Chen L; Jiang B; Di J; Zhang C; Wang Z; Zhang N; Xing J; Cui M; Yang H; Yao Z; Su X Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):914-9. PubMed ID: 26404690 [TBL] [Abstract][Full Text] [Related]
53. TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer. Guadagni F; Roselli M; Cosimelli M; Mannella E; Tedesco M; Cavaliere F; Grassi A; Abbolito MR; Greiner JW; Schlom J Cancer; 1993 Oct; 72(7):2098-106. PubMed ID: 8374868 [TBL] [Abstract][Full Text] [Related]
54. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer. Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685 [TBL] [Abstract][Full Text] [Related]
55. A comparative analysis of the serum levels of NCC-ST-439, CEA and CA19-9 in patients with colorectal carcinoma. Iemura K; Moriya Y Eur J Surg Oncol; 1993 Oct; 19(5):439-42. PubMed ID: 8405479 [TBL] [Abstract][Full Text] [Related]
56. The application of C12 biochip in the diagnosis and monitoring of colorectal cancer: systematic evaluation and suggestion for improvement. Chen C; Chen LQ; Yang GL; Li Y J Postgrad Med; 2008; 54(3):186-90. PubMed ID: 18626164 [TBL] [Abstract][Full Text] [Related]
57. Evaluation of predictive markers for patients with advanced colorectal cancer. Byström P; Berglund Å; Nygren P; Wernroth L; Johansson B; Larsson A; Glimelius B Acta Oncol; 2012 Sep; 51(7):849-59. PubMed ID: 22974092 [TBL] [Abstract][Full Text] [Related]
58. [The value of NLR, FIB, CEA and CA19-9 in colorectal cancer]. Qian X; Wang H; Ren Z; Jin F; Pan SY Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Apr; 55(4):499-505. PubMed ID: 33858062 [No Abstract] [Full Text] [Related]
59. The Behavior of MMP-2, MMP-7, MMP-9, and Their Inhibitors TIMP-1 and TIMP-2 in Adenoma-Colorectal Cancer Sequence. Barabás L; Hritz I; István G; Tulassay Z; Herszényi L Dig Dis; 2021; 39(3):217-224. PubMed ID: 32961536 [TBL] [Abstract][Full Text] [Related]
60. Clinical Significance and Role of TK1, CEA, CA 19-9 and CA 72-4 levels in Diagnosis of Colorectal Cancers. Singh S; Kumar R; Kumar U; Kumari R Asian Pac J Cancer Prev; 2020 Nov; 21(11):3133-3136. PubMed ID: 33247667 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]